SG Americas Securities LLC Grows Position in Maximus, Inc. $MMS

SG Americas Securities LLC lifted its holdings in Maximus, Inc. (NYSE:MMS) by 172.2% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 12,014 shares of the health services provider’s stock after buying an additional 7,600 shares during the period. SG Americas Securities LLC’s holdings in Maximus were worth $1,098,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in MMS. Robeco Institutional Asset Management B.V. increased its stake in Maximus by 64.0% during the third quarter. Robeco Institutional Asset Management B.V. now owns 29,644 shares of the health services provider’s stock worth $2,709,000 after acquiring an additional 11,567 shares during the last quarter. apricus wealth LLC purchased a new position in shares of Maximus during the third quarter worth approximately $222,000. Allspring Global Investments Holdings LLC raised its stake in shares of Maximus by 13.9% during the third quarter. Allspring Global Investments Holdings LLC now owns 526,893 shares of the health services provider’s stock valued at $47,879,000 after acquiring an additional 64,207 shares in the last quarter. Merit Financial Group LLC purchased a new stake in shares of Maximus in the third quarter valued at approximately $321,000. Finally, Diversified Trust Co grew its stake in Maximus by 5.4% in the third quarter. Diversified Trust Co now owns 11,604 shares of the health services provider’s stock worth $1,060,000 after purchasing an additional 590 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Insider Activity at Maximus

In related news, insider Michelle F. Link sold 4,039 shares of the business’s stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total transaction of $350,746.76. Following the completion of the transaction, the insider owned 19,542 shares in the company, valued at $1,697,027.28. The trade was a 17.13% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.60% of the stock is currently owned by company insiders.

Maximus Stock Down 0.2%

Shares of NYSE MMS opened at $98.26 on Friday. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $98.83. The stock’s fifty day simple moving average is $86.85 and its two-hundred day simple moving average is $84.18. The stock has a market capitalization of $5.35 billion, a PE ratio of 17.67 and a beta of 0.56. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.77.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, November 20th. The health services provider reported $1.62 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.01). Maximus had a return on equity of 25.23% and a net margin of 5.87%.The company had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.34 billion. During the same quarter last year, the company earned $1.46 earnings per share. The company’s revenue for the quarter was up .2% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. As a group, analysts expect that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Stockholders of record on Friday, February 13th will be given a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date of this dividend is Friday, February 13th. This is an increase from Maximus’s previous quarterly dividend of $0.30. Maximus’s payout ratio is presently 21.58%.

Analyst Ratings Changes

Several equities research analysts have weighed in on MMS shares. Weiss Ratings reiterated a “buy (b-)” rating on shares of Maximus in a report on Monday, December 29th. Zacks Research upgraded Maximus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 30th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Strong Buy”.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.